These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11422610)

  • 1. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3.
    MacDonald GA; Bridle KR; Ward PJ; Walker NI; Houglum K; George DK; Smith JL; Powell LW; Crawford DH; Ramm GA
    J Gastroenterol Hepatol; 2001 Jun; 16(6):599-606. PubMed ID: 11422610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.
    Ramm GA; Crawford DH; Powell LW; Walker NI; Fletcher LM; Halliday JW
    J Hepatol; 1997 Mar; 26(3):584-92. PubMed ID: 9075666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
    Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
    J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload.
    Houglum K; Bedossa P; Chojkier M
    Am J Physiol; 1994 Nov; 267(5 Pt 1):G908-13. PubMed ID: 7977754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
    Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats.
    Stärkel P; Sempoux C; Leclercq I; Herin M; Deby C; Desager JP; Horsmans Y
    J Hepatol; 2003 Oct; 39(4):538-46. PubMed ID: 12971963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
    Nash S; Marconi S; Sikorska K; Naeem R; Nash G
    Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice.
    Padda RS; Gkouvatsos K; Guido M; Mui J; Vali H; Pantopoulos K
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G251-61. PubMed ID: 25501544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome.
    Riva A; Trombini P; Mariani R; Salvioni A; Coletti S; Bonfadini S; Paolini V; Pozzi M; Facchetti R; Bovo G; Piperno A
    World J Gastroenterol; 2008 Aug; 14(30):4745-52. PubMed ID: 18720534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury.
    Niemelä O; Parkkila S; Britton RS; Brunt E; Janney C; Bacon B
    J Lab Clin Med; 1999 May; 133(5):451-60. PubMed ID: 10235128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiquantitative and qualitative assessment of hepatic iron in patients with chronic viral hepatitis: relation with grading, staging and haemochromatosis mutations.
    Vergani A; Bovo G; Trombini P; Caronni N; Arosio C; Malosio I; Fossati L; Roffi L; Piperno A
    Ital J Gastroenterol Hepatol; 1999; 31(5):395-400. PubMed ID: 10470600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis.
    Ramm GA; Ruddell RG
    Semin Liver Dis; 2005 Nov; 25(4):433-49. PubMed ID: 16315137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance-associated hepatic iron overload.
    Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y
    Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
    Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
    Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis is a cofactor in liver injury in hemochromatosis.
    Powell EE; Ali A; Clouston AD; Dixon JL; Lincoln DJ; Purdie DM; Fletcher LM; Powell LW; Jonsson JR
    Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
    Washington K; Wright K; Shyr Y; Hunter EB; Olson S; Raiford DS
    Hum Pathol; 2000 Jul; 31(7):822-8. PubMed ID: 10923919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.